OK
Keiser, Olivia
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| HIV-1 Low-Level Viremia Predicts Viral Failure in Participants on Antiretroviral Therapy in the Swiss HIV Cohort Study | Clinical infectious diseases | 2025 | 9 | 47 | |||
| Low Trauma Fractures in People with HIV : Longitudinal Time Trends in the Swiss HIV Cohort Study 2009-2022 | Clinical infectious diseases | 2025 | 13 | 29 | |||
| Superinfections in Hospitalized COVID-19 Patients (Super COVID-19) : Data from the Multicentric Retrospective CH-SUR Cohort Study in Switzerland | COVID | 2025 | 8 | 6 | |||
| Routine Immunisation Coverage Shows Signs of Recovery at Global Level Postpandemic, but Important Declines Persist in About 20% of Countries | Vaccines | 2025 | 55 | 448 | |||
| Polygenic Risk Scores for Type 2 Diabetes in the Swiss HIV Cohort Study | Journal of acquired immune deficiency syndromes | 2025 | 19 | 0 | |||
| Targeted approaches for acute HIV infection diagnosis in rural Eswatini | International journal of STD & AIDS | 2025 | 7 | 28 | |||
| Determinants of Nurturing Care Behaviours in Malawi : An Ethnographic Study | Maternal and child nutrition | 2025 | 9 | 14 | |||
| Untargeted Metabolite Profile Associations with Body Mass Index, Waist-Hip Ratio, and Antiretroviral Therapy in >1300 People with HIV : the Swiss HIV Cohort Study | The journal of infectious diseases | 2025 | 6 | 25 | |||
| Types of Myocardial Infarction in People With HIV in Switzerland | Open forum infectious diseases | 2025 | 8 | 36 | |||
| An integrated airborne transmission risk assessment model for respiratory viruses : short- and long-range contributions | Journal of the Royal Society interface | 2025 | 11 | 91 | |||
| Epidemiological analysis and potential factors affecting the 2022-23 Crimean-Congo hemorrhagic fever outbreak in Iraq | European journal of public health | 2025 | 7 | 78 | |||
| Late Re-Engagement Into HIV Care Among Adults in the Swiss HIV Cohort Study | Journal of acquired immune deficiency syndromes | 2025 | 15 | 0 | |||
| Trends in Costs for HIV Care During a Hepatitis C Virus Early Treatment and Elimination Program : A Data Linkage Study of Claims and Swiss HIV Cohort Study Data | Open forum infectious diseases | 2025 | 8 | 8 | |||
| Frequent hepatitis B surface antigen (HBsAg) clearance during tenofovir therapy in persons with HIV/hepatitis B virus coinfection | HIV medicine | 2025 | 13 | 0 | |||
| Leukocyte count and new-onset diabetes mellitus in people with HIV : A longitudinal study | HIV medicine | 2025 | 11 | 14 | |||
| Willingness to participate in clinical trials and expectations towards antiretroviral therapy among heavily treatment-experienced people living with HIV : A feasibility survey | HIV medicine | 2025 | 11 | 29 | |||
| Overview and evaluation of a nationwide hospital-based surveillance system for influenza and COVID-19 in Switzerland (CH-SUR) : 2018–2023 | Swiss medical weekly | 2025 | 13 | 80 | |||
| Estimation of the number of people affected by post COVID-19 condition in Switzerland in 2023 : a mathematical model | International journal of infectious diseases | 2025 | 9 | 49 | |||
| Type I interferon autoantibody footprints reveal neutralizing mechanisms and allow inhibitory decoy design | The journal of experimental medicine | 2025 | 7 | 53 | |||
| Pre-pandemic national immunisation programme strength and health workforce capacity improved routine immunisation resilience during the COVID-19 pandemic | Public health | 2025 | 7 | 35 | |||
| Low sensitivity of the fourth-generation antigen/antibody HIV rapid diagnostic test Determine™ HIV Early Detect for detection of acute HIV infection at the point of care in rural Eswatini : a diagnostic accuracy study | Journal of the International AIDS Society | 2025 | 11 | 218 | |||
| Bottleneck Analysis of Maternal, Newborn and Child Health Services in Underserved Areas of Kwale County, Kenya | Health services insights | 2025 | 18 | 53 | |||
| Long-term levels of protection of different types of immunity against the Omicron variant : a rapid literature review | Swiss medical weekly | 2024 | 93 | 135 | |||
| Missing the vulnerable-Inequalities in social protection in 13 sub-Saharan African countries : Analysis of population-based surveys | PLOS global public health | 2024 | 5 | 10 | |||
| External Validation of Serologic Scores for the Detection of Liver Steatosis Among People With HIV | Open forum infectious diseases | 2024 | 8 | 36 | |||
| Time Trends in Causes of Death in People With HIV : Insights From the Swiss HIV Cohort Study | Clinical infectious diseases | 2024 | 8 | 55 | |||
| Real-world trough concentrations and effectiveness of long-acting cabotegravir and rilpivirine : a multicenter prospective observational study in Switzerland | The Lancet regional health. Europe | 2024 | 6 | 42 | |||
| Effect of Direct Acting Antiviral Drugs on the Occurrence and Recurrence of Intra- and Extra-Hepatic Malignancies in Patients with Chronic Hepatitis C Virus Infection | Cancers | 2024 | 5 | 10 | |||
| Swiss COVID-19 hospital surveillance : an in-depth analysis of the factors associated with hospital readmission dynamics in community-acquired COVID-19 cases | Swiss medical weekly | 2024 | 88 | 225 | |||
| Gender Disparities in Statin Prescriptions in People With HIV With Low/Moderate to High Cardiovascular Risk | Open forum infectious diseases | 2024 | 4 | 16 | |||
| Association of institutional masking policies with healthcare-associated SARS-CoV-2 infections in Swiss acute care hospitals during the BA.4/5 wave (CH-SUR study) : a retrospective observational study | Antimicrobial resistance and infection control | 2024 | 79 | 128 | |||
| Clinical severity of Delta and 3 different Omicron sublineages in patients hospitalized because of COVID-19 in a Swiss tertiary center | CMI communications | 2024 | 63 | 87 | |||
| Infectious disease events in people with HIV receiving kidney transplantation : Analysis of the Swiss HIV Cohort Study and the Swiss Transplant Cohort Study | BMC infectious diseases | 2024 | 62 | 100 | |||
| Population pharmacokinetics of rilpivirine following oral administration and long-acting intramuscular injection in real-world people with HIV | Frontiers in pharmacology | 2024 | 5 | 11 | |||
| Factors Associated with Reliable Contact Tracing During the 2021 Ebola Virus Disease Outbreak in Guinea | Journal of epidemiology and global health | 2024 | 188 | 96 | |||
| Weight, Anthropometric and Metabolic Changes After Discontinuing Antiretroviral Therapy Containing Tenofovir Alafenamide in People With HIV | Clinical infectious diseases | 2024 | 4 | 27 | |||
| Cohort profile : the Swiss Mother and Child HIV Cohort Study (MoCHiV) | BMJ open | 2024 | 5 | 10 | |||
| Patient and public involvement in HIV research : a mapping review and development of an online evidence map | Journal of the International AIDS Society | 2024 | 3 | 34 | |||
| Factors associated with viral load testing and viral suppression among HIV-positive female sex workers in Nigeria | PloS one | 2024 | 6 | 11 | |||
| Spatial pattern of all cause excess mortality in Swiss districts during the pandemic years 1890, 1918 and 2020 | Spatial and spatio-temporal epidemiology | 2024 | 7 | 12 | |||
| Self-reported neurocognitive complaints in the Swiss HIV Cohort Study : a viral genome-wide association study | Brain communications | 2024 | 8 | 25 | |||
| Impact of hormonal therapy on HIV-1 immune markers in cis women and gender minorities | HIV medicine | 2024 | 4 | 18 | |||
| Costs and acceptability of simplified monitoring in HIV-suppressed patients switching to dual therapy : the SIMPL'HIV open-label, factorial randomised controlled trial | Swiss medical weekly | 2024 | 12 | 41 | |||
| Evaluating tuberculosis treatment outcomes in Haiti from 2018 to 2019 : A competing risk analysis | IJID regions | 2024 | 81 | 106 | |||
| Immune response to the recombinant herpes zoster vaccine in people living with HIV over 50 years of age compared to non-HIV age-/gender-matched controls (SHINGR’HIV) : a multicenter, international, non-randomized clinical trial study protocol | BMC infectious diseases | 2024 | 124 | 157 | |||
| In-hospital outcomes of healthcare-associated COVID-19 (Omicron) versus healthcare-associated influenza : a retrospective, nationwide cohort study in Switzerland | Clinical infectious diseases | 2024 | 52 | 140 | |||
| Deciphering Factors Linked With Reduced Severe Acute Respiratory Syndrome Coronavirus 2 Susceptibility in the Swiss HIV Cohort Study | The journal of infectious diseases | 2024 | 7 | 13 | |||
| Differences in condom access and use and associated factors between persons with and without disabilities receiving social cash transfers in Luapula province, Zambia-A cross-sectional study | PloS one | 2024 | 6 | 32 | |||
| Circulating HBV RNA and Hepatitis B Core-Related Antigen Trajectories in Persons With HIV/HBV Coinfection and Hepatitis B Surface Antigen Loss During Tenofovir Therapy | The journal of infectious diseases | 2024 | 4 | 15 | |||
| Economic burden of chronic obstructive pulmonary disease and post-tuberculosis sequelae in low- and middle-income countries : a database compiled from a systematic review and meta-analysis | BMJ public health | 2024 | 6 | 65 | |||
| Population Pharmacokinetics of Cabotegravir Following Oral Administration and Long‐Acting Intramuscular Injection in Real‐World People with HIV | Clinical pharmacology and therapeutics | 2024 | 91 | 189 | |||
| Antibody and T-cell response to bivalent booster SARS-CoV-2 vaccines in people with compromised immune function (COVERALL-3) | The journal of infectious diseases | 2024 | 517 | 487 | |||
| Long-term trends in hepatitis C prevalence, treatment uptake and liver-related events in the Swiss HIV Cohort Study | Liver international | 2024 | 6 | 42 | |||
| Loss of tolerance precedes triggering and lifelong persistence of pathogenic type I interferon autoantibodies | The journal of experimental medicine | 2024 | 5 | 33 | |||
| Trends in Mortality in People With HIV From 1999 through 2020 : A Multicohort Collaboration | Clinical infectious diseases | 2024 | 6 | 8 | |||
| Long-term quantitative hepatitis B surface antigen (HBsAg) trajectories in persons with and without HBsAg loss on tenofovir-containing antiretroviral therapy | HIV medicine | 2024 | 15 | 29 | |||
| Impact of Integrase Inhibitors on Cardiovascular Disease Events in People With Human Immunodeficiency Virus Starting Antiretroviral Therapy | Clinical infectious diseases | 2023 | 103 | 116 | |||
| Analysis of global routine immunisation coverage shows disruption and stagnation during the first two-years of the COVID-19 pandemic with tentative recovery in 2022 | Vaccine. X | 2023 | 66 | 28 | |||
| Antiretroviral Drug Exposure and Response in Obese and Morbidly Obese People With Human Immunodeficiency Virus (HIV) : A Study Combining Modelling and Swiss HIV Cohort Data | Clinical infectious diseases | 2023 | 116 | 91 | |||
| Investing in preparedness for rapid detection and control of epidemics: analysis of health system reforms and their effect on 2021 Ebola virus disease epidemic response in Guinea | BMJ global health | 2023 | 379 | 120 | |||
| Viral suppression and retention in HIV care during the postpartum period among women living with HIV : a longitudinal multicenter cohort study | The Lancet regional health. Europe | 2023 | 65 | 19 | |||
| Historical visit attendance as predictor of treatment interruption in South African HIV patients : Extension of a validated machine learning model | PLOS global public health | 2023 | 67 | 202 | |||
| Effect of SLCO1B1 c.521T>C polymorphism on the lipid response to statins in people living with HIV on a boosted protease inhibitor‐containing regimen | British journal of clinical pharmacology | 2023 | 105 | 90 | |||
| External validation of the Dat'AIDS score : A risk score for predicting 5-year overall mortality in people living with HIV aged 60 years or older | HIV medicine | 2023 | 95 | 72 | |||
| The spatial spread of HIV in Malawi : An individual-based mathematical model | Heliyon | 2023 | 87 | 70 | |||
| An Automated Literature Review Tool (LiteRev) for Streamlining and Accelerating Research Using Natural Language Processing and Machine Learning: Descriptive Performance Evaluation Study | JMIR. Journal of medical internet research | 2023 | 173 | 228 | |||
| Hepatitis B Virus (HBV) Replication During Tenofovir Therapy Is Frequent in Human Immunodeficiency Virus/HBV Coinfection | Clinical infectious diseases | 2023 | 112 | 0 | |||
| COVID-19 preventive social-behavioural practices and exposure to SARS-CoV-2 among residents in the city of Yaounde : Lessons from the early phase of the pandemic in Cameroon | PLOS global public health | 2023 | 67 | 75 | |||
| Differences between persons with and without disability in HIV prevalence, testing, treatment, and care cascade in Tanzania : a cross-sectional study using population-based data | BMC public health | 2023 | 102 | 138 | |||
| Comparison of five different risk scores to predict incident type 2 diabetes in the Swiss HIV cohort study | AIDS | 2023 | 117 | 53 | |||
| Association of a Polygenic Risk Score With Osteoporosis in People Living With HIV : The Swiss HIV Cohort Study | The Journal of infectious diseases | 2023 | 96 | 49 | |||
| Antibody Response After the Third SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients and People Living With HIV (COVERALL-2) | Open forum infectious diseases | 2023 | 92 | 75 | |||
| Triggers of change in sexual behavior among people with HIV: The Swiss U = U statement and Covid-19 compared | The journal of infectious diseases | 2023 | 117 | 83 | |||
| A community-based contact isolation strategy to reduce the spread of Ebola virus disease: an analysis of the 2018-2020 outbreak in the Democratic Republic of the Congo | BMJ global health | 2023 | 185 | 118 | |||
| Polygenic Risk Scores for Prediction of Subclinical Coronary Artery Disease in Persons With Human Immunodeficiency Virus (HIV): The Swiss HIV Cohort Study | Clinical infectious diseases | 2023 | 101 | 44 | |||
| Antibody Response After Third Vaccination With mRNA-1273 or BNT162b2 : Extension of a Randomized Controlled SARS-CoV-2 Noninferiority Vaccine Trial in Patients With Different Levels of Immunosuppression (COVERALL-2) | Open forum infectious diseases | 2023 | 140 | 90 | |||
| Sexual Behaviour and STI Incidence in Sexually Active MSM Living With HIV in Times of COVID-19 | Open forum infectious diseases | 2023 | 128 | 146 | |||
| Socioeconomic inequalities in cervical precancer screening among women in Ethiopia, Malawi, Rwanda, Tanzania, Zambia and Zimbabwe : analysis of Population-Based HIV Impact Assessment surveys | BMJ open | 2023 | 9 | 39 | |||
| Prevalence of HIV-1 drug resistance mutations in proviral DNA in the Swiss HIV Cohort Study, a retrospective study from 1995 to 2018 | The journal of antimicrobial chemotherapy | 2023 | 146 | 209 | |||
| Validation and Improvement of a Machine Learning Model to Predict Interruptions in Antiretroviral Treatment in South Africa | Journal of acquired immune deficiency syndromes | 2023 | 8 | 22 | |||
| Treatment effect of remdesivir on the mortality of hospitalised COVID-19 patients in Switzerland across different patient groups : a tree-based model analysis | Swiss medical weekly | 2023 | 79 | 42 | |||
| A Platform for Data-Centric, Continuous Epidemiological Analyses (EpiGraphHub) : Descriptive Analysis | JMIR. Journal of medical internet research | 2023 | 84 | 204 | |||
| Dolutegravir in Pregnancy as Compared with Current HIV Regimens in the United States | New England journal of medicine | 2022 | 113 | 0 | |||
| Factors associated with the risk of HIV infection among HIV-exposed infants in Malawi : 2013-2020 | BMJ paediatrics open | 2022 | 87 | 42 | |||
| Sub optimal HIV status ascertainment at antenatal clinics and the impact on HIV prevalence estimates : A cross sectional study | PloS one | 2022 | 176 | 86 | |||
| COVID-19 in Switzerland real-time epidemiological analyses powered by EpiGraphHub | Scientific data | 2022 | 78 | 24 | |||
| Associations of Sustainable Development Goals Accelerators With Adolescents' Well-Being According to Head-of-Household's Disability Status-A Cross-Sectional Study From Zambia | International journal of public health | 2022 | 185 | 135 | |||
| Case Report: COVID-19 and Lassa Fever Coinfection in an Ebola Suspected Patient in Guinea | The American journal of tropical medicine and hygiene | 2022 | 341 | 198 | |||
| CD4:CD8 Ratio and CD8 Cell Count and Their Prognostic Relevance for Coronary Heart Disease Events and Stroke in Antiretroviral Treated Individuals: The Swiss HIV Cohort Study | Journal of acquired immune deficiency syndromes | 2022 | 100 | 91 | |||
| Hospital outcomes of community-acquired COVID-19 versus influenza: Insights from the Swiss hospital-based surveillance of influenza and COVID-19 | Euro surveillance | 2022 | 288 | 183 | |||
| Time to death and risk factors associated with mortality among COVID-19 cases in countries within the WHO African region in the early stages of the COVID-19 pandemic | Epidemiology and infection | 2022 | 232 | 178 | |||
| Transfer of antiretroviral drugs into breastmilk : a prospective study from the Swiss Mother and Child HIV Cohort Study | Journal of antimicrobial chemotherapy | 2022 | 95 | 59 | |||
| A Systematic Molecular Epidemiology Screen Reveals Numerous Human Immunodeficiency Virus (HIV) Type 1 Superinfections in the Swiss HIV Cohort Study | The journal of infectious diseases | 2022 | 125 | 0 | |||
| An in-depth statistical analysis of the COVID-19 pandemic's initial spread in the WHO African region | BMJ global health | 2022 | 284 | 195 | |||
| Factors associated with HIV viral suppression among children and adults receiving antiretroviral therapy in Malawi in 2021: Evidence from the Laboratory Management Information System | TM & IH. Tropical medicine and international health | 2022 | 122 | 32 | |||
| Diagnosis and case finding according to key partner risk populations of people living with HIV in Nigeria: A retrospective analysis of community-led index partner testing services | EClinicalMedicine | 2022 | 587 | 146 | |||
| COVID-19 pandemic in Africa's island nations during the first 9 months: a descriptive study of variation in patterns of infection, severe disease, and response measures | BMJ global health | 2022 | 186 | 240 | |||
| Investigation of and Strategies to Control the Final Cluster of the 2018–2020 Ebola Virus Disease Outbreak in the Eastern Democratic Republic of Congo | Open forum infectious diseases | 2022 | 295 | 142 | |||
| Prediction of HIV status based on socio-behavioural characteristics in East and Southern Africa | PloS one | 2022 | 250 | 147 | |||
| Leveraging human resources for outbreak analysis: lessons from an international collaboration to support the sub-Saharan African COVID-19 response | BMC public health | 2022 | 412 | 116 | |||
| Geospatial model of COVID-19 spreading and vaccination with event Gillespie algorithm | Nonlinear dynamics | 2022 | 194 | 117 | |||
| A call for citizen science in pandemic preparedness and response: beyond data collection | BMJ global health | 2022 | 240 | 87 | |||
| Quantifying and predicting ongoing Human Immunodeficiency Virus Type 1 (HIV-1) transmission dynamics in Switzerland using a distance-based clustering approach | The journal of infectious diseases | 2022 | 141 | 2 | |||
| A highly virulent variant of HIV-1 circulating in the Netherlands | Science | 2022 | 197 | 84 | |||
| Developing and testing a Corona VaccinE tRiAL pLatform (COVERALL) to study Covid-19 vaccine response in immunocompromised patients | BMC infectious diseases | 2022 | 142 | 78 | |||
| Decrease of condom use in heterosexual couples and its impact on pregnancy rates: the Swiss HIV Cohort Study (SHCS) | HIV medicine | 2022 | 116 | 104 | |||
| Antibody Response in Immunocompromised Patients After the Administration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine BNT162b2 or mRNA-1273: A Randomized Controlled Trial | Clinical infectious diseases | 2022 | 147 | 74 | |||
| SARS-CoV-2 aerosol transmission in schools: the effectiveness of different interventions | Swiss medical weekly | 2022 | 256 | 161 | |||
| Access to Social Protection by People Living with, at Risk of, or Affected by HIV in Eswatini, Malawi, Tanzania, and Zambia: Results from Population-Based HIV Impact Assessments | AIDS and behavior | 2022 | 322 | 156 | |||
| COVID-19 vaccines and post-vaccination data: Literature update (11) - 30.11.2021 | 2021 | 431 | 251 | ||||
| Evolution of COVID-19 mortality over time: results from the Swiss hospital surveillance system (CH-SUR) | Swiss medical weekly | 2021 | 416 | 121 | |||
| Analysing the reported incidence of COVID-19 and factors associated in the World Health Organization African region as of 31 December 2020 | Epidemiology and infection | 2021 | 289 | 114 | |||
| COVID-19 in the WHO African Region: using risk assessment to inform decisions on public health and social measures | Epidemiology and infection | 2021 | 318 | 129 | |||
| Information management practices in the WHO African Region to support response to the COVID-19 pandemic | Epidemiology and Infection | 2021 | 260 | 119 | |||
| COVID-19 vaccines in the WHO's Emergency Use Listing (EUL) Report (10) - 15.12.2021 | 2021 | 401 | 158 | ||||
| Insights into household transmission of SARS-CoV-2 from a population-based serological survey | Nature Communications | 2021 | 439 | 232 | |||
| COVID-19 vaccines in the WHO's Emergency Use Listing (EUL) Report (Updated Version 7) - 02.11.2021 | 2021 | 267 | 83 | ||||
| COVID-19 vaccines and post-vaccination data: Literature update (9) - 30.09.2021 | 2021 | 345 | 152 | ||||
| The COVID-19 pandemic in the WHO African region: the first year (February 2020 to February 2021) | Epidemiology and infection | 2021 | 409 | 193 | |||
| Estimating the SARS-CoV2 infections detection rate and cumulative incidence in the World Health Organization African Region ten months into the pandemic | Epidemiology and infection | 2021 | 282 | 159 | |||
| COVID-19 mortality in women and men in sub-Saharan Africa: a cross-sectional study | BMJ global health | 2021 | 304 | 156 | |||
| COVID-19 vaccines and post-vaccination data: Literature update (12) - 20.12.2021 | 2021 | 289 | 114 | ||||
| Risk factors for severe outcomes for COVID-19 patients hospitalised in Switzerland during the first pandemic wave, February to August 2020: prospective observational cohort study | Swiss medical weekly | 2021 | 345 | 134 | |||
| Association of Incomplete Adherence to Antiretroviral Therapy With Cardiovascular Events and Mortality in Virologically Suppressed Persons With HIV: The Swiss HIV Cohort Study | Open Forum Infectious Diseases | 2021 | 318 | 183 | |||
| Clusters of sub-Saharan African countries based on sociobehavioural characteristics and associated HIV incidence | PeerJ | 2021 | 510 | 154 | |||
| Novel Use of Capture-Recapture Methods to Estimate Completeness of Contact Tracing during an Ebola Outbreak, Democratic Republic of the Congo, 2018-2020 | Emerging infectious diseases | 2021 | 308 | 167 | |||
| The first eight months of COVID-19 pandemic in three West African countries: leveraging lessons learned from responses to the 2014-2016 Ebola virus disease outbreak | Epidemiology and infection | 2021 | 322 | 135 | |||
| COVID-19 vaccines in the WHO's Emergency Use Listing (EUL) Report (8) - 15.11.2021 | 2021 | 298 | 253 | ||||
| Recommandations pour le suivi des patients atteints d'hépatite C guérie | Swiss Medical Forum | 2021 | 238 | 186 | |||
| COVID-19 vaccines in the WHO's Emergency Use Listing (EUL) Report (4) - 13.09.2021 | 2021 | 317 | 302 | ||||
| Evidence-based Definition for Extensively Drug-resistant Tuberculosis | American Journal of Respiratory and Critical Care Medicine | 2021 | 353 | 459 | |||
| COVID-19 vaccines in the WHO's Emergency Use Listing (EUL) Report (6) - 15.10.2021 | 2021 | 260 | 323 | ||||
| Implementing epidemic intelligence in the WHO African region for early detection and response to acute public health events | Epidemiology and Infection | 2021 | 319 | 167 | |||
| Assessing relative COVID-19 mortality: a Swiss population-based study | BMJ Open | 2021 | 420 | 133 | |||
| Women with disabilities in hearing: the last mile in the elimination of mother-to-child transmission of HIV - a cross-sectional study from Zambia | AIDS care | 2021 | 261 | 144 | |||
| Monitoring and Evaluation of COVID-19 response in the WHO African Region: challenges and lessons learned | Epidemiology and Infection | 2021 | 342 | 159 | |||
| The role of children and adolescents in the SARS-CoV-2 pandemic: a rapid review | Swiss medical weekly | 2021 | 330 | 143 | |||
| COVID-19 vaccines and post-vaccination data: Literature update (Updated Version 10) - 02.11.2021 | 2021 | 293 | 157 | ||||
| Cohort profile: SARS-CoV-2/COVID-19 hospitalised patients in Switzerland | Swiss Medical Weekly | 2021 | 366 | 309 | |||
| Tuberculosis in the Western Pacific Region: Estimating the burden of disease and return on investment 2020–2030 in four countries | The Lancet Regional Health - Western Pacific | 2021 | 233 | 136 | |||
| COVID-19 vaccines in the WHO's Emergency Use Listing (EUL) Report (2) - 16.08.2021 | 2021 | 299 | 394 | ||||
| COVID-19 vaccines in the WHO's Emergency Use Listing (EUL) Report (3) - 30.08.2021 | 2021 | 314 | 357 | ||||
| Evaluation of Early Warning, Alert and Response system for Ebola virus disease, Democratic Republic of the Congo, 2018–2020 | Emerging infectious diseases | 2021 | 405 | 218 | |||
| COVID-19 vaccines and post-vaccination data: literature update (8) - 30.08.2021 | 2021 | 418 | 124 | ||||
| Hepatitis C core antigen test as an alternative for diagnosing HCV infection: mathematical model and cost-effectiveness analysis | PeerJ | 2021 | 371 | 125 | |||
| SARS-CoV-2 antibody seroprevalence and associated risk factors in an urban district in Cameroon | Nature communications | 2021 | 300 | 155 | |||
| Assessing relative COVID-19 mortality during the second wave: a prospective Swiss population-based study | BMJ open | 2021 | 220 | 100 | |||
| A public health strategy for SARS-CoV-2, grounded in science, should guide Swiss schools through the coming winter | Swiss medical weekly | 2021 | 409 | 152 | |||
| Geographical Disparities in HIV Seroprevalence Among Men Who Have Sex with Men and People Who Inject Drugs in Nigeria: Exploratory Spatial Data Analysis | JMIR Public Health and Surveillance | 2021 | 369 | 320 | |||
| COVID-19 vaccines in the WHO's Emergency Use Listing (EUL) Report (9) - 30.11.2021 | 2021 | 281 | 297 | ||||
| COVID-19 vaccines in the WHO's Emergency Use Listing (EUL) Report (5) - 30.09.2021 | 2021 | 307 | 294 | ||||
| Systematic review of Integrated Disease Surveillance and Response (IDSR) implementation in the African region | PLOS ONE | 2021 | 435 | 454 | |||
| Cohort-Derived Machine Learning Models for Individual Prediction of Chronic Kidney Disease in People Living With Human Immunodeficiency Virus: A Prospective Multicenter Cohort Study | The journal of infectious diseases | 2021 | 106 | 38 | |||
| Facing the quality of life: physical illness, anxiety, and depression symptoms among people living with HIV in rural Zambia - a cross-sectional study | AIDS care | 2021 | 223 | 312 | |||
| The toll of COVID-19 on African children: A descriptive analysis on the COVID-19-related morbidity and mortality among the pediatric population in Sub-Saharan Africa | International Journal of Infectious Diseases | 2021 | 222 | 196 | |||
| The Impact of Binge Drinking on Mortality and Liver Disease in the Swiss HIV Cohort Study | Journal of clinical medicine | 2021 | 83 | 90 | |||
| Precision global health: a roadmap for augmented action | Journal of Public Health and Emergency | 2020 | 999 | 413 | |||
| Identifying groups of people with similar sociobehavioural characteristics in Malawi to inform HIV interventions: a latent class analysis | Journal of the International AIDS society | 2020 | 329 | 141 | |||
| Zimbabwe's national third-line antiretroviral therapy program: Cohort description and treatment outcomes | PLOS ONE | 2020 | 264 | 152 | |||
| Antiretroviral Drugs Associated With Subclinical Coronary Artery Disease in the Swiss Human Immunodeficiency Virus Cohort Study | Clinical Infectious Diseases | 2020 | 233 | 0 | |||
| Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study | The Lancet | 2020 | 779 | 14 | |||
| Diagnosis of latent tuberculosis infection is associated with reduced HIV viral load and lower risk for opportunistic infections in people living with HIV | PLoS biology | 2020 | 98 | 29 | |||
| Future scenarios for the SARS-CoV-2 epidemic in Switzerland: an age-structured model | F1000Research | 2020 | 383 | 78 | |||
| Mortality trends and causes of death among HIV positive patients at Newlands Clinic in Harare, Zimbabwe | PLOS ONE | 2020 | 328 | 179 | |||
| Use of electronic tools for evidence-based preparedness and response to the COVID-19 pandemic in the WHO African region | The Lancet Digital Health | 2020 | 293 | 153 | |||
| Social determinants of male partner attendance in women's prevention-of mother-to-child transmission program in Malawi | BMC Public Health | 2020 | 274 | 182 | |||
| Social, Behavioral, and Cultural factors of HIV in Malawi: Semi-Automated Systematic Review | Journal of Medical Internet Research | 2020 | 370 | 646 | |||
| Measuring Timeliness of Outbreak Response in the World Health Organization African Region, 2017-2019 | Emerging Infectious Diseases | 2020 | 324 | 116 | |||
| How helpful are the European AIDS Clinical Society cognitive screening questions in predicting cognitive impairment in an aging, well-treated HIV-positive population? | HIV medicine | 2020 | 118 | 52 | |||
| Impact of Genetic and Nongenetic Factors on Body Mass Index and Waist-Hip Ratio Change in HIV-Infected Individuals Initiating Antiretroviral Therapy | Open Forum Infectious Diseases | 2020 | 236 | 128 | |||
| All-Cause mortality and causes of death in the Swiss Hepatitis C Cohort Study (SCCS) | Open Forum Infectious Diseases | 2020 | 383 | 182 | |||
| Variations in tuberculosis prevalence, russian federation: a multivariate approach | Bulletin of the World Health Organization | 2019 | 471 | 309 | |||
| Precision Global Health - The case of Ebola: a scoping review | Journal of Global Health | 2019 | 666 | 330 | |||
| Modelling the impact of different testing strategies for HCV infection in switzerland | Journal of virus eradication | 2019 | 427 | 115 | |||
| Cost-per-diagnosis as a metric for monitoring cost-effectiveness of HIV testing programmes in low-income settings in Southern Africa: health economic and modelling analysis | Journal of the International AIDS society | 2019 | 449 | 250 | |||
| Long-term retention on antiretroviral therapy among infants, children, adolescents and adults in Malawi: A cohort study | PLOS ONE | 2019 | 339 | 187 | |||
| Impact of geographic origin on access to therapy and therapy outcomes in the Swiss Hepatitis C Cohort Study | PLOS ONE | 2019 | 466 | 219 | |||
| Emtricitabine and lamivudine concentrations in saliva: a simple suitable test for treatment adherence | The journal of antimicrobial chemotherapy | 2019 | 84 | 0 | |||
| "I do all I can but I still fail them": Health system barriers to providing Option B+ to pregnant and lactating women in Malawi | PLOS ONE | 2019 | 386 | 207 | |||
| Changing trends in international versus domestic HCV transmission in HIV-positive MSM: A perspective for the DAA scale-up era | The Journal of Infectious Diseases | 2019 | 816 | 258 | |||
| A case report of untreatable HIV infection in Harare, Zimbabwe | Southern African Journal of HIV Medicine | 2019 | 382 | 153 | |||
| Mortality from suicide among people living with HIV and the general Swiss population: 1988-2017 | Journal of the International AIDS society | 2019 | 391 | 163 | |||
| Very low hepatitis C viral loads in treatment-naïve persons: do they compromise hepatitis C virus antigen testing? | Clinical Infectious Diseases | 2019 | 539 | 175 | |||
| Programme national de lutte contre le VIH, les IST et l'hépatite virale: unir les forces contre le VIH et les hépatites virales | Bulletin des médecins suisses | 2019 | 483 | 210 | |||
| Research priorities to inform "Treat All" policy implementation for people living with HIV in sub-Saharan Africa: a consensus statement from the International epidemiology Databases to Evaluate AIDS (IeDEA) | Journal of the International AIDS society | 2019 | 778 | 468 | |||
| Timing of combination antiretroviral therapy (cART) initiation is not associated with stillbirth among HIV-infected pregnant women in Malawi | Tropical Medicine & International Health | 2019 | 489 | 222 | |||
| Socio‐behavioural characteristics and HIV: findings from a graphical modelling analysis of 29 sub‐Saharan African countries | Journal of the International AIDS society | 2019 | 390 | 167 | |||
| Why do sub‐Saharan Africans present late for HIV care in Switzerland ? | HIV medicine | 2019 | 89 | 0 | |||
| On the potential of a short-term intensive intervention to interrupt HCV transmission in HIV-positive men who have sex with men: A mathematical modelling study | Journal of viral hepatitis | 2018 | 1,749 | 478 | |||
| How should HIV resources be allocated? Lessons learnt from applying Optima HIV in 23 countries | Journal of the International AIDS society | 2018 | 643 | 262 | |||
| Eliminating hepatitis C virus as a public health threat among HIV-positive men who have sex with men: a multi-modelling approach to understand differences in sexual risk behaviour | Journal of the International AIDS society | 2018 | 1,633 | 374 | |||
| Long-term Immune Response to Yellow Fever Vaccination in Human Immunodeficiency Virus (HIV)-Infected Individuals Depends on HIV RNA Suppression Status: Implications for Vaccination Schedule | Clinical infectious diseases | 2018 | 90 | 0 | |||
| Patterns of caesarean section in HIV infected and non-infected women in Malawi: is caesarean section used for PMTCT? | BMC Pregnancy and Childbirth | 2018 | 565 | 222 | |||
| Impact of Screening and Treatment for Hepatitis C Virus (HCV) Infection in Switzerland. A Comprehensive Mathematical Model of the Swiss HCV Epidemic | 2018 | 605 | 165 | ||||
| The global Optima HIV allocative efficiency model: targeting resources in efforts to end AIDS | The Lancet HIV | 2018 | 1,187 | 564 | |||
| Mathematical modelling to inform 'treat all' implementation in sub-Saharan Africa: a scoping review | Journal of Virus Eradication | 2018 | 405 | 147 | |||
| The Effect of Monitoring Viral Load and Tracing Patients Lost to Follow-up on the Course of the HIV Epidemic in Malawi: A Mathematical Model | Open Forum Infectious Diseases | 2018 | 1,505 | 376 | |||
| Combler les lacunes dans les tests de dépistage de l'hépatite | Bulletin des médecins suisses | 2018 | 473 | 196 | |||
| HIV-1 Drug Resistance and Third-Line Therapy Outcomes in Patients Failing Second-Line Therapy in Zimbabwe | Open Forum Infectious Diseases | 2018 | 694 | 270 | |||
| Weight gain of HIV-exposed, uninfected children born before and after introduction of the "Option B+" programme in Malawi | AIDS | 2018 | 450 | 210 | |||
| Cohort profile: The MULTI sTUdy Diabetes rEsearch (MULTITUDE) consortium | BMJ Open | 2018 | 560 | 215 | |||
| Outcomes of Patients Lost to Follow-up in African Antiretroviral Therapy Programs: Individual Patient Data Meta-analysis | Clinical Infectious Diseases | 2018 | 472 | 205 | |||
| Subclinical coronary artery disease in Swiss HIV-positive and HIV-negative persons | European heart journal | 2018 | 103 | 0 | |||
| A community outbreak of Legionnaires' disease in Geneva, Switzerland, June to September 2017 | Swiss Medical Weekly | 2018 | 526 | 261 | |||
| "I found that I was well and strong": Women's motivations for remaining on ART under Option B+ in Malawi | PLOS ONE | 2018 | 562 | 219 | |||
| HIV transmission and retention in care among HIV-exposed children enrolled in Malawi's prevention of mother-to-child transmission programme | Journal of the International AIDS society | 2017 | 620 | 358 | |||
| The cascade of care to prevent mother-to-child transmission in Rio de Janeiro, Brazil, 1996-2013: improving but still some way to go | Tropical Medicine & International Health | 2017 | 512 | 330 | |||
| New-onset type 2 diabetes mellitus among patients receiving HIV care at Newlands Clinic, Harare, Zimbabwe: retrospective cohort analysis | Tropical Medicine & International Health | 2017 | 580 | 267 | |||
| Getting it right when budgets are tight: Using optimal expansion pathways to prioritize responses to concentrated and mixed HIV epidemics | PLOS ONE | 2017 | 568 | 285 | |||
| Trends in hepatitis C-related mortality in Switzerland | Journal of Hepatology | 2017 | 1,253 | 792 | |||
| Impact of screening and antiretroviral therapy on anal cancer incidence in HIV-positive MSM | AIDS | 2017 | 591 | 379 | |||
| The J-Curve in HIV: Low and Moderate Alcohol Intake Predicts Mortality but Not the Occurrence of Major Cardiovascular Events | Journal of acquired immune deficiency syndromes | 2016 | 86 | 0 | |||
| Ability to Work and Employment Rates in Human Immunodeficiency Virus (HIV)-1-Infected Individuals Receiving Combination Antiretroviral Therapy : The Swiss HIV Cohort Study | Open forum infectious diseases | 2016 | 86 | 48 | |||
| Hepatitis C virus transmission among human immunodeficiency virus-infected men who have sex with men: Modeling the effect of behavioral and treatment interventions | Hepatology | 2016 | 707 | 325 | |||
| Characteristics of Foreign-Born Persons in the Swiss Hepatitis C Cohort Study: Implications for Screening Recommendations | PloS one | 2016 | 633 | 562 | |||
| Immunodeficiency and the risk of cervical intraepithelial neoplasia 2/3 and cervical cancer: A nested case-control study in the Swiss HIV cohort study | International journal of cancer | 2016 | 693 | 324 | |||
| Emergence of Acquired HIV-1 Drug Resistance Almost Stopped in Switzerland: A 15-Year Prospective Cohort Analysis | Clinical Infectious Diseases | 2016 | 681 | 1 | |||
| HIV-1 Transmission During Recent Infection and During Treatment Interruptions as Major Drivers of New Infections in the Swiss HIV Cohort Study | Clinical Infectious Diseases | 2016 | 519 | 210 | |||
| Increases in Condomless Sex in the Swiss HIV Cohort Study | Open forum infectious diseases | 2015 | 91 | 64 | |||
| Transient detectable viremia and the risk of viral rebound in patients from the Swiss HIV Cohort Study | BMC infectious diseases | 2015 | 105 | 84 | |||
| Neighbourhood socio-economic position, late presentation and outcomes in people living with HIV in Switzerland | AIDS | 2015 | 94 | 0 | |||
| Reasons for late presentation to HIV care in Switzerland | Journal of the International AIDS Society | 2015 | 74 | 42 | |||
| Effect of Cumulating Exposure to Abacavir on the Risk of Cardiovascular Disease Events in Patients From the Swiss HIV Cohort Study | Journal of acquired immune deficiency syndromes | 2015 | 102 | 34 | |||
| HBV genotypes and response to tenofovir disoproxil fumarate in HIV/HBV-coinfected persons | BMC gastroenterology | 2015 | 79 | 31 | |||
| Self-reported nonadherence to antiretroviral therapy as a predictor of viral failure and mortality | AIDS | 2015 | 76 | 0 | |||
| Effect of baseline renal function on tenofovir-containing antiretroviral therapy outcomes in Zambia | Clinical infectious diseases | 2014 | 729 | 306 | |||
| Social Meets Molecular: Combining Phylogenetic and Latent Class Analyses to Understand HIV-1 Transmission in Switzerland | American journal of epidemiology | 2014 | 871 | 72 | |||
| Virologic and immunologic responses in treatment-naive patients to ritonavir-boosted atazanavir or efavirenz with a common backbone | HIV clinical trials | 2014 | 83 | 0 | |||
| Risk factors for anal cancer in persons infected with HIV: a nested case-control study in the Swiss HIV Cohort Study | American journal of epidemiology | 2013 | 676 | 0 | |||
| Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection | British journal of cancer | 2012 | 585 | 1,089 | |||
| Longer term clinical and virological outcome of sub-Saharan African participants on antiretroviral treatment in the Swiss HIV Cohort Study | Journal of acquired immune deficiency syndromes | 2012 | 637 | 0 | |||
| Estimating loss to follow-up in HIV-infected patients on antiretroviral therapy: the effect of the competing risk of death in Zambia and Switzerland | PloS one | 2011 | 1,280 | 370 | |||
| Immunovirological response to triple nucleotide reverse-transcriptase inhibitors and ritonavir-boosted protease inhibitors in treatment-naive HIV-2-infected patients : The ACHIEV2E Collaboration Study Group | Clinical infectious diseases | 2011 | 104 | 0 | |||
| A randomized crossover study to compare efavirenz and etravirine treatment | AIDS | 2011 | 105 | 0 | |||
| Cellular immune responses to HCV core increase and HCV RNA levels decrease during successful antiretroviral therapy | Gut | 2010 | 660 | 0 | |||
| Pregnancy and delivery outcomes of HIV infected women in Switzerland 2003-2008 | Journal of perinatal medicine | 2010 | 706 | 0 | |||
| Suicide in HIV-infected individuals and the general population in Switzerland, 1988-2008 | The American journal of psychiatry | 2010 | 689 | 0 | |||
| Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study | British journal of cancer | 2010 | 798 | 1 | |||
| Liver enzyme elevation after lamivudine withdrawal in HIV-hepatitis B virus co-infected patients: the Swiss HIV Cohort Study | HIV medicine | 2009 | 630 | 0 | |||
| Public-health and individual approaches to antiretroviral therapy: township South Africa and Switzerland compared | PLoS medicine | 2008 | 866 | 386 | |||
| Antiretroviral treatment during pregnancy | AIDS | 2008 | 675 | 0 | |||
| Durability and outcome of initial antiretroviral treatments received during 2000--2005 by patients in the Swiss HIV Cohort Study | The Journal of infectious diseases | 2008 | 649 | 0 | |||
| Active intravenous drug use during chronic hepatitis C therapy does not reduce sustained virological response rates in adherent patients | Journal of viral hepatitis | 2008 | 651 | 0 | |||
| Adverse events to antiretrovirals in the Swiss HIV Cohort Study: effect on mortality and treatment modification | Antiviral therapy | 2007 | 583 | 1 |
